Literature DB >> 2882515

Mapping the X-linked lymphoproliferative syndrome.

J C Skare, A Milunsky, K S Byron, J L Sullivan.   

Abstract

The X-linked lymphoproliferative syndrome is triggered by Epstein-Barr virus infection and results in fatal mononucleosis, immunodeficiency, and lymphoproliferative disorders. This study shows that the mutation responsible for X-linked lymphoproliferative syndrome is genetically linked to a restriction fragment length polymorphism detected with the DXS42 probe (from Xq24-q27). The most likely recombination frequency between the loci is 4%, and the associated logarithm of the odds is 5.26. Haplotype analysis using flanking restriction fragment length polymorphism markers indicates that the locus for X-linked lymphoproliferative syndrome is distal to probe DXS42 but proximal to probe DXS99 (from Xq26-q27). It is now possible to predict which members of a family with X-linked lymphoproliferative syndrome are carrier females and to diagnose the syndrome prenatally.

Entities:  

Mesh:

Year:  1987        PMID: 2882515      PMCID: PMC304574          DOI: 10.1073/pnas.84.7.2015

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  13 in total

1.  Acquired agammaglobulinemia after a life-threatening illness with clinical and laboratory features of infectious mononucleosis in three related male children.

Authors:  A J Provisor; J J Iacuone; R R Chilcote; R G Neiburger; F G Crussi
Journal:  N Engl J Med       Date:  1975-07-10       Impact factor: 91.245

2.  Fatal infectious mononucleosis in a family.

Authors:  R S Bar; C J DeLor; K P Clausen; P Hurtubise; W Henle; J F Hewetson
Journal:  N Engl J Med       Date:  1974-02-14       Impact factor: 91.245

3.  Estimation of the recombination fraction in human pedigrees: efficient computation of the likelihood for human linkage studies.

Authors:  J Ott
Journal:  Am J Hum Genet       Date:  1974-09       Impact factor: 11.025

4.  Report of the Committee on Human Gene Mapping by Recombinant DNA Techniques.

Authors:  H F Willard; M H Skolnick; P L Pearson; J L Mandel
Journal:  Cytogenet Cell Genet       Date:  1985

5.  X-linked lymphoproliferative syndrome: abnormal antibody responses to bacteriophage phi X 174.

Authors:  H D Ochs; J L Sullivan; R J Wedgwood; J K Seeley; K Sakamoto; D T Purtilo
Journal:  Birth Defects Orig Artic Ser       Date:  1983

6.  A strategy to reveal high-frequency RFLPs along the human X chromosome.

Authors:  J Aldridge; L Kunkel; G Bruns; U Tantravahi; M Lalande; T Brewster; E Moreau; M Wilson; W Bromley; T Roderick
Journal:  Am J Hum Genet       Date:  1984-05       Impact factor: 11.025

7.  Variable phenotypic expression of an X-linked recessive lymphoproliferative syndrome.

Authors:  D T Purtilo; D DeFlorio; L M Hutt; J Bhawan; J P Yang; R Otto; W Edwards
Journal:  N Engl J Med       Date:  1977-11-17       Impact factor: 91.245

8.  X-linked recessive progressive combined variable immunodeficiency (Duncan's disease).

Authors:  D T Purtilo; C K Cassel; J P Yang; R Harper
Journal:  Lancet       Date:  1975-04-26       Impact factor: 79.321

9.  Abnormal anti-Epstein Barr virus antibodies in carriers of the X-linked lymphoproliferative syndrome and in females at risk.

Authors:  K Sakamoto; J K Seeley; T Lindsten; J Sexton; J Yetz; M Ballow; D T Purtilo
Journal:  J Immunol       Date:  1982-02       Impact factor: 5.422

10.  X-linked lymphoproliferative syndrome. Natural history of the immunodeficiency.

Authors:  J L Sullivan; K S Byron; F E Brewster; S M Baker; H D Ochs
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

View more
  12 in total

1.  Linkage analysis of seven kindreds with the X-linked lymphoproliferative syndrome (XLP) confirms that the XLP locus is near DXS42 and DXS37.

Authors:  J C Skare; H L Grierson; J L Sullivan; R L Nussbaum; D T Purtilo; B S Sylla; G M Lenoir; D S Reilly; B N White; A Milunsky
Journal:  Hum Genet       Date:  1989-07       Impact factor: 4.132

Review 2.  X-linked lymphoproliferative disease (XLP) as a model of Epstein-Barr virus-induced immunopathology.

Authors:  D T Purtilo
Journal:  Springer Semin Immunopathol       Date:  1991

3.  Prenatal diagnosis of X linked lymphoproliferative disease using multiplex polymerase chain reaction.

Authors:  V Schuster; S Seidenspinner; H W Kreth
Journal:  J Med Genet       Date:  1995-09       Impact factor: 6.318

4.  Molecular genetic haplotype segregation studies in three families with X-linked lymphoproliferative disease.

Authors:  V Schuster; S Seidenspinner; T Grimm; W Kress; S Zielen; M Bock; H W Kreth
Journal:  Eur J Pediatr       Date:  1994-06       Impact factor: 3.183

Review 5.  Epstein-Barr virus and human diseases: recent advances in diagnosis.

Authors:  M Okano; G M Thiele; J R Davis; H L Grierson; D T Purtilo
Journal:  Clin Microbiol Rev       Date:  1988-07       Impact factor: 26.132

Review 6.  Epstein-Barr virus infection and associated diseases in children. I. Pathogenesis, epidemiology and clinical aspects.

Authors:  V Schuster; H W Kreth
Journal:  Eur J Pediatr       Date:  1992-10       Impact factor: 3.183

Review 7.  XLP: clinical features and molecular etiology due to mutations in SH2D1A encoding SAP.

Authors:  Stuart G Tangye
Journal:  J Clin Immunol       Date:  2014-08-02       Impact factor: 8.317

8.  Genetic study of a new X-linked recessive immunodeficiency syndrome.

Authors:  G de Saint-Basile; F Le Deist; M Caniglia; Y Lebranchu; C Griscelli; A Fischer
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

9.  Tightly linked flanking markers for the Lowe oculocerebrorenal syndrome, with application to carrier assessment.

Authors:  D S Reilly; R A Lewis; D H Ledbetter; R L Nussbaum
Journal:  Am J Hum Genet       Date:  1988-05       Impact factor: 11.025

10.  Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome.

Authors:  K E Nichols; D P Harkin; S Levitz; M Krainer; K A Kolquist; C Genovese; A Bernard; M Ferguson; L Zuo; E Snyder; A J Buckler; C Wise; J Ashley; M Lovett; M B Valentine; A T Look; W Gerald; D E Housman; D A Haber
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.